Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Bass, Berry & Sims Releases Annual Review of 2015 Securities and Shareholder Litigation

Firm Publication

Publications

March 10, 2016

Securities & Shareholder 2015 Year-End ReviewBass, Berry & Sims PLC announces the release of the Securities & Shareholder Litigation: 2015 Year-End Review, the firm's annual report on the most important trends and developments from the previous year affecting companies and their officers and directors. The report provides an extensive analysis of and practical guidance regarding the most significant updates in corporate and securities law in 2015.

The six key trends and topics covered in the report include:

  • The establishment of the Tennessee Business Court in 2015.
  • How different lower courts have interpreted the scope of the Supreme Court's decision in Omnicare, and the implications of these varying interpretations.
  • Whether the rejection of disclosure-only settlements in Delaware's Chancery Court will mean the death of these types of settlements or will it force companies to seek other jurisdictions?
  • What is the risk of liability for financial advisors in light of several recent court decisions?
  • Updates and analysis on some of the most significant securities cases of 2015, including Pension Fund Group v. Tempur-Pedic Int'l, Inc., Bondali v. Yum! Brands, Inc., and Verble v. Morgan Stanley Smith Barney, LLC.
  • Attorney-client privilege considerations for in-house counsel of companies with global operations or affiliates.

Click below to view the Securities & Shareholder Litigation 2015 Year-End Review. We hope this review is useful. If you have any questions about the survey or would like additional information about the articles or the authors, please contact one of the authors listed. We look forward to working with you in the future.

Download Document - Securities & Shareholder 2015 Year-End Review

In Case You Missed It:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.